Any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology. (Source: Biosafety Protocol, Article 3 paragraph g Cartagena Protocol)
(g) (g) Establish or maintain means to regulate, manage or control the risks associated with the use and release of living modified organisms resulting from biotechnology which are likely to have adverse environmental impacts that could affect the conservation and sustainable use of biologival diversity, taking also into account the risks to human health.
Handling of Biotechnology and Distribution of its Benefits
3. 3. The Parties shall consider the need for and modalities of a protocol setting out appropriate procedures, including, in particular, advance informed agreement, in the field of the safe transfer, handling and use of any living modified organism resulting from biotechnology that may have adverse effect on the conservation and sustainable use of biological diversity.
4. 4. Each Contracting Party shall, directly or by requiring any natural or legal person under its jurisdiction providing the organisms referred to in paragraph 3 above, provide any available information about the use and safety regulations required by that Contracting Party in handling such organisms, as well as any available information on the potential adverse impact of the specific organisms concerned to the Contracting Party into which those organisms are to be introduced.
Cartagena Protocol
الاتفاقية المتعلقة بالتنوع البيولوجي